4.8 Article

Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients

Yang Li et al.

Summary: By analyzing the serum IgG response of 1,051 COVID-19 patients, researchers identified linear epitopes of the SARS-CoV-2 Spike protein, revealing two regions rich in linear epitopes and identifying variable peptide responses associated with disease severity. Antibodies obtained from immunizing mice with linear epitopes did not show significant neutralizing activity against the virus, suggesting the importance of understanding humoral responses for vaccine refinement.

CELL REPORTS (2021)

Letter Respiratory System

Autoimmunity to annexin A2 predicts mortality among hospitalised COVID-19 patients

Marisol Zuniga et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Immunology

Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19

Ana Rodriguez-Perez et al.

Summary: The study found that COVID-19 patients had higher levels of AA-AT1 and AA-ACE2, which were significantly associated with disease severity. Patients with mild disease had lower levels of autoantibodies than those with moderate or severe disease, with no significant differences between males and females.

JOURNAL OF AUTOIMMUNITY (2021)

Article Medicine, General & Internal

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Qun Li et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Article Hematology

COVID-19 and its implications for thrombosis and anticoagulation

Jean M. Connors et al.

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

Article Microbiology

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Evangelos J. Giamarellos-Bourboulis et al.

CELL HOST & MICROBE (2020)

Review Medicine, General & Internal

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

Paolo Verdecchia et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

Temporal dynamics in viral shedding and transmissibility of COVID-19

Xi He et al.

NATURE MEDICINE (2020)

Article Immunology

ACE2, Much More Than Just a Receptor for SARS-COV-2

Lobelia Samavati et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Editorial Material Urology & Nephrology

Blockade of SARS-CoV-2 infection by recombinant soluble ACE2

Francois Alhenc-Gelas et al.

KIDNEY INTERNATIONAL (2020)

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Article Cell Biology

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

Yu Zuo et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Review Physiology

ACE2, angiotensin-(1-7), and Mas: the other side of the coin

Michael Bader

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2013)

Review Biochemistry & Molecular Biology

Virus interactions with endocytic pathways in macrophages and dendritic cells

Jason Mercer et al.

TRENDS IN MICROBIOLOGY (2013)

Article Rheumatology

Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases

Yuko Takahashi et al.

ARTHRITIS RESEARCH & THERAPY (2010)

Review Immunology

Immunity and immunopathology to viruses: what decides the outcome?

Barry T. Rouse et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Article Peripheral Vascular Disease

Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension

MLX Fu et al.

JOURNAL OF HYPERTENSION (2000)